通过分析护理研究生在我院近5年撰写的科研项目申报书、中标与参与课题研究、在国内外学术期刊论文的发表、协助指导论文和参与国内外学术交流活动的情况,从而探讨护理研究生在医院临床科研工作中的角色和作用。
ObjectiveTo investigate the protective effect and mechanism of betaxolol on optic nerves after experimental retinal ischemia-reperfused injury.MethodsRetinal ischemia was induced in SD rats by increasing intraocular pressure through intracameral infusion. Sixty-eight rats were randomly divided into 3 groups: normal control (eight rats), 0.25% betaxolol treatment (thirty rats) and saline control group (thirty rats). The latter two groups were subdivided into group 1 day, 3 and 7 days after reperfusion, respectively, with 10 rats in each group. Betaxolol and normal saline was applied to the right eyes of the rats in the treatment group and to the ones in normal saline control group, respectively. The amplitude of bwave of electron retinograph (ERG) was observed and the histological and ultrastructural changes were detected by light and electron microscopy. The expression of neural nitrogen oxide synthase (nNOS) was detected by immunohistochemistry. The content of malonyldialdehyde (MDA) and the superoxide dismutase (SOD) activity were measured by spectrophotometer.ResultsBegan from the first day after reperfusion, in saline control group, the amplitudes of ERG bwave reduced continuously, the histopathological damages of retina were aggravating, the expression of nNOS increased, MDA level increased and SOD level decreased persistently, which significantly differed from the normal control group （P＜0.01）; in contrast to the saline control group, the amplitudes of bwave of ERG in betaxolol treatment group after reperfusion got right obviously（P＜0.01）, with alleviated histopathological damages, decreased nNOS positive neurons（P＜0.01）, decreased MDA content（P＜0.01）, and increased SOD activity （P＜0.01）, in which no statistical significance of nNOS positive neurons was found between the treatment group and normal control group （P＞0.01）. ConclusionBetaxolol, by reducing intracellular overfreight ofCa2+, inhibiting production of NO and elevating the ability of anti-oxidation in rat retina, can protect retinal neurons from ischemiareperfused injury.(Chin J Ocul Fundus Dis, 2005,21:249-252)
ObjectiveTo investigate the effect of triamcinolone acetonide (TA) with different dosage and excipient on retina.MethodsThirty-two purebred New Zealand white rabbits randomly divided into 4 groups underwent intravitreous injection with TA. Group 1:4 mg TA without excipient; group 2:25 mg TA without excipient; group 3:4 mg TA with excipient; group 4:25 mg TA with excipient. Electroretinography (ERG) was performed on each rabbit before intravitreal injection, 1 week, 1 and 2 months after the injection. All the animals were killed and the eyeballs were extirpated 2 months after the injection, and pathological examinations including light and electron microscopy were performed.ResultsNo significant difference was found in the latent period of ERG at the points of time before and after the injection in all the groups, but the amplitudes of ERG waves was lower in groups containing excipient than that before the treatment (Plt; 0.01). The results of light and electron microscopy showed damages of tissue or structures of retina in various degrees in groups containing excipient.ConclusionIntravitreous injection of TA with the dosage of ≤25 mg without excipient does no harm to the retinal configuration and function, and excipient may lead to the change of retinal configuration and function.(Chin J Ocul Fundus Dis, 2005,21:229-232)
摘要:目的: 观察地耳草颗粒对慢性肾功能不全的治疗效果。 方法 :观察23例患者治疗前后血肌酐、尿素氮、 血浆白蛋白、血色素的变化。 结果 :地耳草颗粒可明显降低患者血肌酐、尿素氮水平;并提高患者血浆白蛋白和血色素水平。 结论 :地耳草颗粒对慢性肾功能不全有一定的治疗效果。Abstract: Objective: To observe the clinic efficacy of Hypericum japonicum Thunb on treatment of 23 patients with chronic renal insufficiency diseases. Methods : Observe the change of Bun, Scr, Hb, Alb level after the treatment by Hypericum japonicum Thunb. Results : the Bun and Scr declined, Hb and Alb level raised after the treatment. Conclusion : Hypericum japonicum Thunb has some therapeutic effects on chronic renal insufficiency diseases.